Current diagnostic biomarkers in thyroid cancer include point mutations in the BRAF, NRAS, KRAS, HRAS genes, and rearrangements in paired box 8 (PAX8)/peroxisome proliferator-activated receptor gamma (PPARG) and RET [15,16,17,18]. Here, BRAF is linked to thyroid gland carcinoma.